Diana D. Shi

De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma

R. Deberardinis, K. Ligon, D. Cahill, 2022, Cancer cell.

Creation and Development of Patient-Derived Organoids for Therapeutic Screening in Solid Cancer

K. Abdullah, J. Traylor, W. H. Hicks, 2022, Current Stem Cell Reports.

Creation and Development of Patient-Derived Organoids for Therapeutic Screening in Solid Cancer

K. Abdullah, J. Traylor, W. H. Hicks, 2022, Current Stem Cell Reports.

Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome

I. Braun, M. Kulke, S. Minden, 2017, Cancer.

DNA damage in IDH-mutant gliomas: mechanisms and clinical implications

K. Abdullah, S. McBrayer, Diana D. Shi, 2022, Journal of Neuro-Oncology.

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials

Xiaoran Zhang, K. Abdullah, Z. Gersey, 2023, Neuro-oncology advances.

Synthesis and Biological Evaluation of Bis-CNB-GABA, a Photoactivatable Neurotransmitter with Low Receptor Interference and Chemical Two-Photon Uncaging Properties

S. Wang, Federico F. Trigo, M. Semmelhack, 2014, Journal of the American Chemical Society.

Emerging roles of nucleotide metabolism in cancer.

K. Abdullah, S. McBrayer, Milan R. Savani, 2023, Trends in cancer.